TMO

Thermo Fisher Scientific Inc.

Technology
473.95 -8.13 -1.69% Market Closed
2026-06-03 • USD

Key Metrics

Market Cap 176.13B
EV —
Shares Out 371.62M
Revenue (ttm) 45.20B
Net Income 6.85B
Beta —
P/E 25.75
Forward P/E —
EPS (ttm) $18.19
P/S 3.90
P/B 3.39
P/FCF —
P/C —
EV/Sales —
EV/EBITDA —
ROA 6.05%
ROE 13.37%
ROIC 7.49%
Gross Margin —
Oper. Margin 17.46%
Profit Margin 15.15%
Debt/Eq 0.89
LT Debt/Eq 45.26%
Quick Ratio —
Current Ratio 1.53
Book/sh 139.61
Cash/sh 8.75
Div Yield 0.37%
Div TTM $1.76
Payout Ratio 9.68%
SMA20 2.69%
SMA50 -1.29%
SMA200 -10.02%
Volume 1,938,882
Avg Volume 2.32M
Rel Volume —
Perf Week -3.77%
Perf Month 1.54%
Perf Quarter -8.65%
Perf Half Y -17.25%
Perf YTD -18.21%
Perf Year 18.98%
Perf 3Y -8.61%
Perf 5Y 5.61%

Factor Lens

Seasonal Performance

Dividends

Per-share amounts adjusted for stock splits.

Last Dividend $0.4700
TTM Yield 0.37%
TTM Amount $1.76
Payout Ratio 9.68%
3-Yr Growth (CAGR) 12.75%
5-Yr Growth (CAGR) 14.34%

Last 12 Payouts

Period Ex-Date Amount / Share
Q1 2026 ~2026-03-28 $0.4700
Q4 2025 ~2025-12-27 $0.4300
Q3 2025 ~2025-09-27 $0.4300
Q2 2025 ~2025-06-28 $0.4300
Q1 2025 ~2025-03-29 $0.4300
Q4 2024 ~2024-12-28 $0.3900
Q3 2024 ~2024-09-28 $0.3900
Q2 2024 ~2024-06-29 $0.3900
Q1 2024 ~2024-03-30 $0.3900
Q4 2023 ~2023-12-30 $0.3500
Q3 2023 ~2023-09-30 $0.3500
Q2 2023 ~2023-07-01 $0.3500

Financial Trends

Revenue & Net Income

Earnings Per Share

Margins

Cash Flow

Company Overview

Thermo Fisher Scientific Inc. is the world leader in serving science with a mission to enable customers to make the world healthier, cleaner and safer. The company provides an unrivaled combination of innovative technologies, purchasing convenience, and outsourced manufacturing and clinical research services through its industry-leading brands including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. The company serves life sciences research, analytical challenges, laboratory productivity, patient diagnostics and development/manufacturing of life-changing medicines. Operating through four reportable segments—Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services—Thermo Fisher maintains an extensive global footprint with operations across North America, Europe, Asia Pacific and other regions. In 2025, the company generated $44.56 billion in revenue, employed over 120,000 colleagues, and invested $1.4 billion in research and development to drive innovation across its businesses.

Name
Thermo Fisher Scientific Inc.
Industry
Technology
CEO
Marc N. Casper · Chairman and Chief Executive Officer
Employees
120,000 as of 2025-12-31
IPO Date
2019-03-05
Phone
7816221000
Address
168 Third Avenue, Waltham, MA 02451
Website
www.thermofisher.com

Key Executives

Name Title FY Pay
Michel Lagarde Executive Vice President —
Frederick Lowery Executive Vice President —
Stephen Williamson Chief Financial Officer (former) —
James Meyer Chief Financial Officer —
Marc N. Casper Chairman and Chief Executive Officer —

Latest News